The effect of Cinnamase drops on family members of patients with Covid 19

Effect of Cinnamase drops on the incidence of clinical symptoms in asymptomatic individuals in the family of under treatment Covid 19 patients

Status

Recruiting

Phases

Phase 2

Study type

Interventional

Source

IRCT

Registry ID

IRCT20210515051305N1

Enrollment

100

Registered

2021-07-10

Start date

2021-06-16

Completion date

Unknown

Last updated

2021-07-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

coronavirus disease. COVID-19, virus identified

Interventions

Intervention 1: Intervention group: 50 healthy persons in contact with the Covid-19 patient use one drop of Cinnamase ?oil in each side of their nose twice a day for 7 days. They should not take other

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Definitive diagnosis of Covid 19 for a member of family based on clinical symptoms and positive PCR ?test result.? Signing consent form by volunteers participating in the study Volunteers should not have Covid-19 symptoms for two weeks prior to the study Volunteers should not participate in other clinical trials Volunteers should not use supplements (containing vitamins, minerals and probiotics) or other ?preventive treatments.?

Exclusion criteria

Exclusion criteria: Allergy to herbal medicines and and natural oils

Design outcomes

Primary

Measure	Time frame
Clinical signs of coronavirus disease. Timepoint: Before starting the study,7,14 days after the start of the study. Method of measurement: Questionnaire.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMohsen Naseri

Shahed University

naseri@shahed.ac.ir66464320

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026